121 related articles for article (PubMed ID: 22036089)
1. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.
Hlinkova K; Babal P; Berzinec P; Majer I; Mikle-Barathova Z; Piackova B; Ilencikova D
Diagn Mol Pathol; 2013 Jun; 22(2):70-5. PubMed ID: 23628817
[TBL] [Abstract][Full Text] [Related]
3. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.
Sriram KB; Tan ME; Savarimuthu SM; Wright CM; Relan V; Stockwell RE; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
Eur Respir J; 2011 Oct; 38(4):903-10. PubMed ID: 21349912
[TBL] [Abstract][Full Text] [Related]
4. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.
Kawahara A; Yamamoto C; Nakashima K; Azuma K; Hattori S; Kashihara M; Aizawa H; Basaki Y; Kuwano M; Kage M; Mitsudomi T; Ono M
Clin Cancer Res; 2010 Jun; 16(12):3163-70. PubMed ID: 20423982
[TBL] [Abstract][Full Text] [Related]
7. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
Sequist LV; Joshi VA; Jänne PA; Bell DW; Fidias P; Lindeman NI; Louis DN; Lee JC; Mark EJ; Longtine J; Verlander P; Kucherlapati R; Meyerson M; Haber DA; Johnson BE; Lynch TJ
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4403s-4408s. PubMed ID: 16857818
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cohen V; Agulnik JS; Ang C; Kasymjanova G; Batist G; Small D; Brandao G; Chong G; Miller WH
Cancer; 2010 Sep; 116(18):4309-17. PubMed ID: 20549828
[TBL] [Abstract][Full Text] [Related]
10. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis.
Smith GD; Chadwick BE; Willmore-Payne C; Bentz JS
J Clin Pathol; 2008 Apr; 61(4):487-93. PubMed ID: 17908804
[TBL] [Abstract][Full Text] [Related]
11. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
[TBL] [Abstract][Full Text] [Related]
13. Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer.
Hsiao SH; Chung CL; Lee CM; Chen WY; Chou YT; Wu ZH; Chen YC; Lin SE
Clin Lung Cancer; 2013 Nov; 14(6):719-25. PubMed ID: 23891241
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
[TBL] [Abstract][Full Text] [Related]
15. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F
J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868
[TBL] [Abstract][Full Text] [Related]
16. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
[TBL] [Abstract][Full Text] [Related]
17. Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' project.
Janssens A; De Droogh E; Lefebure A; Kockx M; Pauwels P; Germonpre P; van Meerbeeck JP
Acta Clin Belg; 2014 Apr; 69(2):92-7. PubMed ID: 24724747
[TBL] [Abstract][Full Text] [Related]
18. Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer.
Wang S; An T; Wang J; Zhao J; Wang Z; Zhuo M; Bai H; Yang L; Zhang Y; Wang X; Duan J; Wang Y; Guo Q; Wu M
Clin Cancer Res; 2010 Feb; 16(4):1324-30. PubMed ID: 20145159
[TBL] [Abstract][Full Text] [Related]
19. Detection of EGFR mutation in tissue samples of non-small-cell lung cancer by a fluorescence polarization assay.
Liu W; Li X; Zhang Z; Chen Y; Qiang S; Cheng H; Fan L; Liang P; Zhang J
Diagn Mol Pathol; 2012 Sep; 21(3):138-42. PubMed ID: 22847157
[TBL] [Abstract][Full Text] [Related]
20. The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases.
Pang B; Dettmer M; Ong CW; Dhewar AN; Gupta S; Lim GL; Nga ME; Seet JE; Qasim A; Chin TM; Soo R; Soong R; Salto-Tellez M
Cytopathology; 2012 Aug; 23(4):229-36. PubMed ID: 22805513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
